Literature DB >> 29759122

Early Diagnosis and Treatment of Rheumatoid Arthritis.

Emily A Littlejohn1, Seetha U Monrad2.   

Abstract

Rheumatoid arthritis is the most common inflammatory arthritis, and a significant cause of morbidity and mortality. Primary care providers should be able to distinguish the clinical presentation of rheumatoid arthritis from osteoarthritis, because the treatment and outcomes differ greatly between these 2 common forms of arthritis. This article provides a current overview of our understanding of rheumatoid arthritis, with an emphasis on early diagnosis and approaches to treatment.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biologic agents; Diagnostic criteria; Disease-modifying antirheumatic drugs; Extra-articular manifestations; Rheumatoid arthritis; Synovitis

Mesh:

Substances:

Year:  2018        PMID: 29759122     DOI: 10.1016/j.pop.2018.02.010

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  56 in total

1.  A Study on Association Between Protein Carbonyl and Anti-cyclic Citrullinated Peptide Antibody in Rheumatoid Arthritis: Introducing a New Supplementary Biomarker.

Authors:  Sahar Khorasani; Nadia Boroumand; Abdolmomen Ghaeni Pasavei; Maryam Sahebari; Seyed Isaac Hashemy
Journal:  Indian J Clin Biochem       Date:  2019-03-05

Review 2.  Is there an association between rheumatoid arthritis and bone changes in the temporomandibular joint diagnosed by cone-beam computed tomography? A systematic review and meta-analysis.

Authors:  Débora E Silva Campos; Isis de Araújo Ferreira Muniz; Natália Lins de Souza Villarim; Isabella Lima Arrais Ribeiro; André Ulisses Dantas Batista; Paulo Rogério Ferreti Bonan; Marcelo Augusto Oliveira de Sales
Journal:  Clin Oral Investig       Date:  2021-02-05       Impact factor: 3.573

3.  Effect of combined application of iguratimod in the treatment of active rheumatoid arthritis on bone metabolism, Th17 cells and Treg cells.

Authors:  Li Wen; Wei Jiang; Meiqun Zhou; Zhenxia Wu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

4.  EZH2 regulates the balance between osteoclast and osteoblast differentiation to inhibit arthritis-induced bone destruction.

Authors:  Fang Cheng; Huimin Li; Jing Liu; Fengfeng Yan; Yu Chen; Haiyan Hu
Journal:  Genes Immun       Date:  2022-05-17       Impact factor: 2.676

5.  Value of combination of 25-(OH)-D3, IL-6, and cyclic peptide containing citrulline antibodies in different stages of rheumatoid arthritis.

Authors:  Rui Chang; Wanying Deng; Xiaoqiang Song; Bing Hu; Xiang Li; Angang Chen; Benqiang Zeng
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 6.  Prevalence of Sarcopenia and its Association with Antirheumatic Drugs in Middle-Aged and Older Adults with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.

Authors:  Thang Dao; Ben Kirk; Steven Phu; Sara Vogrin; Gustavo Duque
Journal:  Calcif Tissue Int       Date:  2021-06-16       Impact factor: 4.333

7.  The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis.

Authors:  Peyvand Parhizkar Roudsari; Sepideh Alavi-Moghadam; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Akram Tayanloo-Beik; Forough Azam Sayahpour; Bagher Larijani; Babak Arjmand
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Radiographic changes in TMJ in relation to serology and disease activity in RA patients.

Authors:  Mostafa Mahmoud Youssef Mohamed; Mushira M Dahaba; Mary Medhat Farid; Adel Mahmoud Ali Elsayed
Journal:  Dentomaxillofac Radiol       Date:  2019-09-20       Impact factor: 2.419

Review 9.  LncRNAs in adaptive immunity: role in physiological and pathological conditions.

Authors:  Pedro Faria Zeni; Marek Mraz
Journal:  RNA Biol       Date:  2020-11-09       Impact factor: 4.652

10.  Wutou decoction attenuates rheumatoid arthritis by modulating the Ahr/LOC101928120/SHC1 pathway.

Authors:  Dan Wu; Xi Li; Jun Liu; Can Hu; Jiefang Li
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.